Literature DB >> 15691618

Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives.

Maxime Lamarre-Cliche1, Jacques de Champlain, Yves Lacourcière, Luc Poirier, Maria Karas, Pierre Larochelle.   

Abstract

BACKGROUND: The aldosterone-to-renin ratio (ARR) is frequently used to screen primary hyperaldosteronism. This study, part of a clinical trial, was designed to measure the influence of circadian rhythms, antihypertensive drugs, and body posture on plasma renin, on aldosterone, and on their interrelation.
METHODS: In a prospective, randomized, open-label, parallel-designed protocol, 57 essential hypertensives (41 men, 16 women) were randomized to a morning dose of telmisartan (80 mg), ramipril (10 mg), or amlodipine (10 mg) for 8 weeks. At baseline and after 8 weeks of therapy, blood pressure (BP), plasma renin (in nanograms per liter), and plasma aldosterone (in picomoles per liter) concentrations were assessed in the supine position every 4 h for 24 h and after 10 min of standing at 9 am.
RESULTS: There was no significant association between renin, aldosterone, the ARR and demographic factors, or BP. Circadian variations of plasma renin and aldosterone were clearly present. Aldosterone variations were of greater relative amplitude with earlier-occurring peaks than renin. The ARR exhibited statistically and clinically significant circadian variations with the low and peak values averaging 55.9 +/- 32.3 and 161.84 +/- 85.4 pmol/L/ng/dL, respectively. Telmisartan, ramipril, and amlodipine significantly decreased the ARR. Telmisartan had the greatest influence on the ARR. Posture had a clinically significant but statistically nonsignificant effect on the ARR.
CONCLUSIONS: Renin, aldosterone, and their interrelation are influenced by circadian rhythms, telmisartan, ramipril, and amlodipine in patients with essential hypertension. Telmisartan has a greater impact on these parameters than ramipril and amlodipine. Measurement of the ARR in treated hypertensive patients should take these influences into account.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15691618     DOI: 10.1016/j.amjhyper.2004.08.025

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  14 in total

1.  Effect of age on aldosterone/renin ratio (ARR) and comparison of screening accuracy of ARR plus elevated serum aldosterone concentration for primary aldosteronism screening in different age groups.

Authors:  Guoshu Yin; Shaoling Zhang; Li Yan; Muchao Wu; Mingtong Xu; Feng Li; Hua Cheng
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

2.  Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.

Authors:  Wei-Guo Chen; Ting-Ting Zhou; Peng Zhou; Xiao-Wei Li; Zhun Wu; Kai-Yan Zhang; Jin-Chun Xing
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 3.  Aldosterone and arterial hypertension.

Authors:  Andreas Tomaschitz; Stefan Pilz; Eberhard Ritz; Barbara Obermayer-Pietsch; Thomas R Pieber
Journal:  Nat Rev Endocrinol       Date:  2009-12-22       Impact factor: 43.330

4.  Separate and interacting effects of the endogenous circadian system and behaviors on plasma aldosterone in humans.

Authors:  Saurabh S Thosar; Jose F Rueda; Alec M Berman; Michael R Lasarev; Maya X Herzig; Noal A Clemons; Sally A Roberts; Nicole P Bowles; Jonathan S Emens; David H Ellison; Steven A Shea
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-12-06       Impact factor: 3.619

5.  Randomized, double-blind, controlled study of losartan in children with proteinuria.

Authors:  Nicholas J A Webb; Chun Lam; Tom Loeys; Shahnaz Shahinfar; Juergen Strehlau; Thomas G Wells; Emanuela Santoro; Denise Manas; Gilbert W Gleim
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

6.  Repeat Adrenal Vein Sampling in Aldosteronism: Reproducibility and Interpretation of Persistently Discordant Results.

Authors:  Gregory A Kline; Alexander Ah-Chi Leung; Davis Sam; Alex Chin; Benny So
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

7.  24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension.

Authors:  Y Lacourcière; N Crikelair; R D Glazer; J Yen; D A Calhoun
Journal:  J Hum Hypertens       Date:  2011-01-20       Impact factor: 3.012

Review 8.  The effect of medication on the aldosterone-to-renin ratio. A critical review of the literature.

Authors:  Rawan M Alnazer; Gregory P Veldhuizen; Abraham A Kroon; Peter W de Leeuw
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-01-18       Impact factor: 3.738

9.  Plasma renin activity and aldosterone concentrations in hypertensive cats with and without azotemia and in response to treatment with amlodipine besylate.

Authors:  R E Jepson; H M Syme; J Elliott
Journal:  J Vet Intern Med       Date:  2013-11-13       Impact factor: 3.333

Review 10.  Confounders of the aldosterone-to-renin ratio when used as a screening test in hypertensive patients: A critical analysis of the literature.

Authors:  Gregory P Veldhuizen; Rawan M Alnazer; Abraham A Kroon; Peter W de Leeuw
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-12-27       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.